30 closest matches · ranked by relevance
Bifascicular Block · Syncope
Primary: Combined Endpoint Defined as First Occurrence Among the Following Events 1)Syncope Episode of Any Origin; 2)Presyncopal Episode With Documented Cardioinhibitory Origin…
Atrioventricular Block · Heart Diseases
Primary: Mortality, Heart Failure-related Urgent Care Visits, or Significant Increase in Left Ventricular End Systolic Volume Index (LVESVI) — 160; 191; 93; 136 participants…
Atrioventricular Block · Ventricular Dysfunction
Primary: Total Mortality — 307; 305 Participants — p=0.3492
Anesthesia
Primary: Number of Patients With Complete Sensory Block — 91; 79 percentage of participants — p=<0.01
Onset and Duration of a Digital Nerve Block
Primary: The Change in the Average Finger Temperature From Baseline to Post-intervention. — -1.35; 0.93 degrees centigrade
Coronary Artery Disease · Myocardial Ischemia
Primary: Number of Participants With Target Vessel Failure (TVF) at 30 Days Post Procedure. — 2 Participants
Coronary Artery Disease · Sternal Pain
Primary: Opioid Consumption — 40.8; 49.1 Milligram Morphine Equivalents (MME)
Bradycardia · Atrioventricular Block · Left Bundle-Branch Block
Primary: Serious Adverse Device Effect (SADE)-Free Rate at 3 Months — 98 Percentage of participants without SADE — p=<0.0001
Atrial Fibrillation
Primary: Freedom From Any Atrial Arrhythmias — 24; 23 Participants — p=.83
Left Ventricular Dysfunction
Primary: Change in Left Ventricular Ejection Fraction From Baseline to 2 Years (Intent to Treat Cohort). — -2.29; -3.43 percentage — p=0.4347
Heart Failure
Primary: Freedom From System-related Complications Through 9 Months Compared to an Objective Performance Criterion — 0.932 Event-Free Probability
Non-left Bundle Branch Block · Ischemic or Non-ischemic Cardiomyopathy
Primary: Number of Patients With Improved Clinical Composite Score — 86; 45 Participants — p=0.001
Bradycardia · Heart Failure
Primary: • ECG Belt Analysis of Standard Deviation of Activation Times (SDAT) of LBBP Compared to Native Conduction — 38.6; 20.5 ms
Rotator Cuff Injury
Primary: Visual Analog Scale (VAS) Pain Score — 2.0; 2.6; 1.7; 2.6 units on a scale
Ventricular Tachycardia
Primary: Number of Participants Achieving Freedom From Recurrent Ventricular Tachycardia (VT) — 16; 29 Participants
Bradycardia
Primary: LVEF — 64.22; 63.14; 59.96 % LVEF — p=0.1734
Heart Failure
Primary: Exercise Capacity as Measured by Peak Oxygen Uptake (Peak VO2) — 9.1; 9.8 mL/kg/min — p=0.053
Cataracts
Primary: Visual Acuity — -0.04; -0.01; 0.14; 0.18 LogMar
Pain, Postoperative · Major Abdominal Surgery
Primary: VRS Pain Score — 4.3; 4.2 score on a scale — p=<0.001
Low Back Pain
Primary: Cost Per Successful Procedure — 15,241; 17,142; 6286 U.S. dollars
Cardiac Surgery · Opioid Use, Unspecified
Primary: Total Opioid Consumption 72 Hours Post-operatively — 165.00; 205.05 morphine milligram equivalents
Local Anesthetic
Primary: Duration of Analgesia. — 7.5; 10 minute — p=0.14
Diaphragm Paralysis
Primary: Abnormal Lung Function — 11; 3 participants w/ abnormal diaphragm fxn
Heart Failure
Primary: Distribution of "Improved", "Unchanged" and "Worsened" Patients as Defined Per M. Packer's Clinical Composite Score — 11; 7; 10; 16 participants
Anesthesia, Conduction
Primary: Skin Temperature Increase From Baseline — 1.9; 2.3 degrees C
Joint Disease · Pain · Pain, Acute
Primary: Number of Participants With Incidence of Hemidiaphragmatic Paralysis (HDP) — 45; 3; 18; 59 participants
Shoulder Arthroscopy
Primary: Number of Patients With Paradoxical Diaphragmatic Movement — 16; 8 Participants
Tendonitis
Primary: Opioid Utilization for the First 24 Hours After Surgery — 17.5; 20 morphine milligram equivalents
Congestive Heart Failure
Primary: Change in Left Ventricular Ejection Fraction (LVEF) — 26.3; 30.5; 31.9; 34.0 ejection fraction percentage — p=<0.001
Atrial Flutter
Primary: Procedure-related Complication-free Rate — 92.7; 98.2 percentage of subjects